
Panagiotis (Panos) A. Konstantinopoulos, MD, PhD
Contact Information
Office Phone Number
Fax
Appointments
On This Page
Biography
Panagiotis (Panos) A. Konstantinopoulos, MD, PhD
Panagiotis (Panos) A Konstantinopoulos, MD, PhD is Director of the Mellen and Eisenson Family Center for BRCA and Related Genes and Director of Translational Research, Division of Gynecologic Oncology. He is also the Velma Eisenson Endowed Chair for Clinical and Translational Research at DFCI and Professor of Medicine at Harvard Medical School. His clinical and translational research career focuses on ovarian and endometrial cancers with a focus on the areas of DNA Damage and Repair and Immunotherapy. His research efforts in this area have been supported by the Department of Defense (DOD), Ovarian Cancer Research Program (OCRP), the American Association of Cancer Research (AACR) and the NIH/NCI. As a clinical researcher, he is involved as a principal investigator (PI) and co-investigator in multiple gynecologic cancer clinical trials and serves as Co-Chair of the NRG Development Therapeutics (Translational Science) Committee. After receiving his MD and PhD from University of Patras in Greece, Dr Konstantinopoulos completed internship and residency at State University of New York at Syracuse, followed by a medical oncology fellowship at Beth Israel Deaconess Medical Center and Harvard Medical School. He also received a Master's degree in Clinical Investigation from Harvard Medical School and Massachusetts Institute of Technology (MIT) Department of Health Sciences and Technology.
Researcher
Physician
Centers/Programs
Clinical Interests
Epithelial ovarian cancer, Novel therapies
Diseases Treated
Board Certification
- Internal Medicine, 2005
- Medical Oncology, 2008
Fellowship
- Beth Israel Deaconess Medical Center, Medical Oncology
Residency
- State University of New York University Hospital, Internal Medicine
Medical School
- University of Patras Medical School
Locations

Dana-Farber Cancer Institute
450 Brookline Avenue Boston, MA 02215Dana-Farber Cancer Institute
